Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258
18 Years
N/A
Both
Cancer
Trial Information
Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258
Chemotherapy teaching sessions, often coordinated in the outpatient setting by nursing
personnel, are meant to educate patients about the chemotherapy they will be receiving.
Education topics include an understanding of side effects, treatment schedule, medications
to treat side effects and how to contact the oncology team if adverse events develop. Some
of these issues are addressed in the American Society of Clinical Oncology's Quality
Oncology Practice Initiative (QOPI). This study will perform an analysis of the teaching
process that is provided prior to chemotherapy administration.
This study will provide data for each participating hospital to individually assess their
teaching process. Multivariate analysis can be performed to evaluate whether age, sex,
native, language, race highest level of education, cancer type, chemotherapy regimen,
institution where chemotherapy will be administered, and type of personnel performing the
teaching visit, influences the effectiveness of the teaching visit. In addition, results
can be compared across different hospitals.This analysis may lead to improvements in each
hospital's chemotherapy teaching practices and lead to advances in patient's cognitive and
emotional preparedness.
Inclusion Criteria:
- Patients > 18 years of age who will be receiving chemotherapy (including targeted
anticancer therapy) at a Brown University Oncology Research Group Affiliated Hospital
for a period of 1-year after study activation.
- Patients who will be undergoing a chemotherapy teaching session at an institution
affiliated with the Brown University Oncology Research Group.
- No prior chemotherapy or targeted anticancer treatment.
- Signed informed consent
Exclusion Criteria:
Patients must meet eligibility criteria
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Evaluate whether chemotherapy teaching sessions improves patient's knowledge, preparedness and anxiety in relation to chemotherapy
Outcome Description:
To evaluate whether chemotherapy teaching sessions improves patient's knowledge, preparedness and anxiety in relation to chemotherapy After informed consent for this study is obtained, patients will be given questionnaire #1 that includes rating their knowledge of the side effects of treatment, their understanding of the treatment schedule, what do in the event of complication, how to reach the medical team and an assessment of the level of anxiety. The questionnaire will be repeated at day 1 of the first chemotherapy treatment to assess the effectiveness of the teaching session. In addition, questionnaire #3 will be administered at day 1 of cycle 2 of their first chemotherapy.
Outcome Time Frame:
up to 1 month
Safety Issue:
No
Principal Investigator
Anthony Mega, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Brown University
Authority:
United States: Institutional Review Board
Study ID:
258
NCT ID:
NCT01827761
Start Date:
October 2011
Completion Date:
October 2013
Related Keywords:
- Cancer
- chemotherapy teaching
- questionnaire
Name | Location |
|---|---|
| Rhode Island Hospital | Providence, Rhode Island 02903 |
| Roger Williams Medical Center | Providence, Rhode Island 02908-4735 |
| The Miriam Hospital | Providence, Rhode Island 02903 |
| Memorial Hospital | Pawtucket, Rhode Island 02860 |
